Sernova (TSE:SVA) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Sernova Corp., a clinical-stage biotech firm, will be featured at the Cell & Gene Meeting on the Mesa where CEO Jonathan Rigby will present advances in cell therapy, including their ongoing diabetes clinical trial and collaborative pre-clinical work for a potential diabetes cure. The company is known for developing the Cell Pouch Transplant System aiming to provide a ‘functional cure’ for diabetes and other chronic diseases through cell therapy.
For further insights into TSE:SVA stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money